List of Tables

Table 2.1: Impact Analysis
Table 5.1: Global Oligonucleotide Synthesis Market Size, By Product, $Million (2018-2029)
Table 5.2: Global Synthesized Oligonucleotides Market Size, By Region/Country, $Million (2018-2029)
Table 5.3: Global Primer Market Size, By Region/Country, $Million (2018-2029)
Table 5.4: Global Probes Market Size, By Region/Country, $Million (2018-2029)
Table 5.5: Global Large-Scale Synthesized Oligonucleotides Market Size, By Region/Country, $Million (2018-2029)
Table 5.6: Global Intermediate-scale synthesized oligonucleotides Market Size, By Region/Country, $Million (2018-2029)
Table 5.7: Global Linkers and Adaptors Market Size, By Region/Country, $Million (2018-2029)
Table 5.8: Global Custom Oligonucleotides Market Size, By Region/Country, $Million (2018-2029)
Table 5.9: Global Pre-design Oligonucleotides Market Size, By Region/Country, $Million (2018-2029)
Table 5.10: Global Oligonucleotide Equipment Market Size, By Region/Country, $Million (2018-2029)
Table 5.11: Global Oligonucleotide Reagent Market Size, By Region/Country, $Million (2018-2029)
Table 5.12: Global Oligonucleotide Services Market Size, By Region/Country, $Million (2018-2029)
Table 6.1: Global Oligonucleotide Synthesis Market, By Application, $Million (2018-2029)
Table 6.2: Global Oligonucleotide Synthesis Market for Research, By Type, 2018-2029 ($Million)
Table 6.3: Global Oligonucleotide Synthesis Market for Research, By Region/Country, 2018-2029 ($Million)
Table 6.4: Global Oligonucleotide Synthesis Market for PCR, By Region/Country, 2018-2029 ($Million)
Table 6.5: Global Oligonucleotide Synthesis Market For qPCR, By Region/Country, 2018-2029 ($Million)
Table 6.6: Global Oligonucleotide Synthesis Market for NGS, By Region/Country, 2018-2029 ($Million)
Table 6.7: Global Oligonucleotide Synthesis Market for Gene Synthesis, By Region/Country, 2018-2029 ($Million)
Table 6.8: Global Oligonucleotide Synthesis Market for Other Application, By Region/Country, 2018-2029 ($Million)
Table 6.9: Global Oligonucleotide Synthesis Market for Therapeutics, By Type, 2018-2029 ($Million)
Table 6.10: Global Oligonucleotide Synthesis Market for Therapeutics, By Region/Country, 2018-2029 ($Million)
Table 6.11: Global Oligonucleotide Synthesis Market for Antisense Therapies, By Region/Country, 2018-2029 ($Million)
Table 6.12: Global Oligonucleotide Synthesis Market for RNA Oligonucleotide Therapies, By Region/Country, 2018-2029 ($Million)
Table 6.13: Global Oligonucleotide Synthesis Market for Other Therapeutic Applications, By Region/Country, 2018-2029 ($Million)
Table 6.14: Global Oligonucleotide Synthesis Market for Diagnostics, By Region/Country, 2018-2029 ($Million)
Table 7.1: Oligonucleotide Synthesis Market (by End User), 2018-2029, $ Million
Table 7.2: Oligonucleotide Synthesis Market for Academic Institutes (by Country/Region), 2018-2029, $Million
Table 7.3: Oligonucleotide Synthesis Market for Pharmaceutical and Biotechnology Companies (by Country/Region), 2018-2029 ($ Million)
Table 7.4: Oligonucleotide Synthesis Market for Diagnostic Laboratories (by Country/Region), 2018-2029 ($ Million)
Table 8.1: Global Oligonucleotide Synthesis Market (by Region), 2018-2029
Table 8.2: North America Oligonucleotide Synthesis Market Revenue (by Country), 2018-2029, $Million
Table 8.3: North America Oligonucleotide Synthesis Market Revenue (by Product), 2018-2029, $Million
Table 8.4: North America Synthesized Oligonucleotide Synthesis Market Revenue (by Synthesized Oligonucleotides), 2018-2029, $Million
Table 8.5: North America Synthesized Oligonucleotide Synthesis Market Revenue (by Modification Type), 2018-2029, $Million
Table 8.6: North America Oligonucleotide Synthesis Market Revenue (by Application), 2018-2029, $Million
Table 8.7: North America Oligonucleotide Synthesis Market Revenue (by Research Application), 2018-2029, $Million
Table 8.8: North America Oligonucleotide Synthesis Market Revenue (by Therapeutic Application), 2018-2029, $Million
Table 8.9: North America Oligonucleotide Synthesis Market Revenue (by End User), 2018-2029, $Million
Table 8.10: U.S. Oligonucleotide Synthesis Market Revenue (by Product), 2018-2029, $Million
Table 8.11: U.S. Synthesized Oligonucleotide Synthesis Market Revenue (by Synthesized Oligonucleotides), 2018-2029, $Million
Table 8.12: U.S. Synthesized Oligonucleotide Synthesis Market Revenue (by Modification Type), 2018-2029, $Million
Table 8.13: U.S. Oligonucleotide Synthesis Market Revenue (by Application), 2018-2029, $Million
Table 8.14: U.S. Oligonucleotide Synthesis Market Revenue (by Research Application), 2018-2029, $Million
Table 8.15: U.S. Oligonucleotide Synthesis Market Revenue (by Therapeutic Application), 2018-2029, $Million
Table 8.16: U.S. Oligonucleotide Synthesis Market Revenue (by End User), 2018-2029, $Million
Table 8.17: Canada Oligonucleotide Synthesis Market Revenue (by Product), 2018-2029, $Million
Table 8.18: Canada Synthesized Oligonucleotide Synthesis Market Revenue (by Synthesized Oligonucleotides), 2018-2029, $Million
Table 8.19: Canada Synthesized Oligonucleotide Synthesis Market Revenue (by Modification Type), 2018-2029, $Million
Table 8.20: Canada Oligonucleotide Synthesis Market Revenue (by Application), 2018-2029, $Million
Table 8.21: Canada Oligonucleotide Synthesis Market Revenue (by Research Application), 2018-2029, $Million
Table 8.22: Canada Oligonucleotide Synthesis Market Revenue (by Therapeutic Application), 2018-2029, $Million
Table 8.23: Canada Oligonucleotide Synthesis Market Revenue (by End User), 2018-2029, $Million
Table 8.24: Europe Oligonucleotide Synthesis Market Revenue (by Country), 2018-2029, $Million
Table 8.25: Europe Oligonucleotide Synthesis Market Revenue (by Product), 2018-2029, $Million
Table 8.26: Europe Synthesized Oligonucleotide Synthesis Market Revenue (by Synthesized Oligonucleotides), 2018-2029, $Million
Table 8.27: Europe Synthesized Oligonucleotide Synthesis Market Revenue (by Modification Type), 2018-2029, $Million
Table 8.28: Europe Oligonucleotide Synthesis Market Revenue (by Application), 2018-2029, $Million
Table 8.29: Europe Oligonucleotide Synthesis Market Revenue (by Research Application), 2018-2029, $Million
Table 8.30: Europe Oligonucleotide Synthesis Market Revenue (by Therapeutic Application), 2018-2029, $Million
Table 8.31: Europe Oligonucleotide Synthesis Market Revenue (by End User), 2018-2029, $Million
Table 8.32: Germany Oligonucleotide Synthesis Market Revenue (by Product), 2018-2029, $Million
Table 8.33: Germany Synthesized Oligonucleotide Synthesis Market Revenue (by Synthesized Oligonucleotides), 2018-2029, $Million
Table 8.34: Germany Synthesized Oligonucleotide Synthesis Market Revenue (by Modification Type), 2018-2029, $Million
Table 8.35: Germany Oligonucleotide Synthesis Market Revenue (by Application), 2018-2029, $Million
Table 8.36: Germany Oligonucleotide Synthesis Market Revenue (by Research Application), 2018-2029, $Million
Table 8.37: Germany Oligonucleotide Synthesis Market Revenue (by Therapeutic Application), 2018-2029, $Million
Table 8.38: Germany Oligonucleotide Synthesis Market Revenue (by End User), 2018-2029, $Million
Table 8.39: U.K. Oligonucleotide Synthesis Market Revenue (by Product), 2018-2029, $Million
Table 8.40: U.K. Synthesized Oligonucleotide Synthesis Market Revenue (by Synthesized Oligonucleotides), 2018-2029, $Million
Table 8.41: U.K. Synthesized Oligonucleotide Synthesis Market Revenue (by Modification Type), 2018-2029, $Million
Table 8.42: U.K. Oligonucleotide Synthesis Market Revenue (by Application), 2018-2029, $Million
Table 8.43: U.K. Oligonucleotide Synthesis Market Revenue (by Research Application), 2018-2029, $Million
Table 8.44: U.K. Oligonucleotide Synthesis Market Revenue (by Therapeutic Application), 2018-2029, $Million
Table 8.45: U.K. Oligonucleotide Synthesis Market Revenue (by End User), 2018-2029, $Million
Table 8.46: France Oligonucleotide Synthesis Market Revenue (by Product), 2018-2029, $Million
Table 8.47: France Synthesized Oligonucleotide Synthesis Market Revenue (by Synthesized Oligonucleotides), 2018-2029, $Million
Table 8.48: France Synthesized Oligonucleotide Synthesis Market Revenue (by Modification Type), 2018-2029, $Million
Table 8.49: France Oligonucleotide Synthesis Market Revenue (by Application), 2018-2029, $Million
Table 8.50: France Oligonucleotide Synthesis Market Revenue (by Research Application), 2018-2029, $Million
Table 8.51: France Oligonucleotide Synthesis Market Revenue (by Therapeutic Application), 2018-2029, $Million
Table 8.52: France Oligonucleotide Synthesis Market Revenue (by End User), 2018-2029, $Million
Table 8.53: Italy Oligonucleotide Synthesis Market Revenue (by Product), 2018-2029, $Million
Table 8.54: Italy Synthesized Oligonucleotide Synthesis Market Revenue (by Synthesized Oligonucleotides), 2018-2029, $Million
Table 8.55: Italy Synthesized Oligonucleotide Synthesis Market Revenue (by Modification Type), 2018-2029, $Million
Table 8.56: Italy Oligonucleotide Synthesis Market Revenue (by Application), 2018-2029, $Million
Table 8.57: Italy Oligonucleotide Synthesis Market Revenue (by Research Application), 2018-2029, $Million
Table 8.58: Italy Oligonucleotide Synthesis Market Revenue (by Therapeutic Application), 2018-2029, $Million
Table 8.59: Italy Oligonucleotide Synthesis Market Revenue (by End User), 2018-2029, $Million
Table 8.60: Spain Oligonucleotide Synthesis Market Revenue (by Product), 2018-2029, $Million
Table 8.61: Spain Synthesized Oligonucleotide Synthesis Market Revenue (by Synthesized Oligonucleotides), 2018-2029, $Million
Table 8.62: Spain Synthesized Oligonucleotide Synthesis Market Revenue (by Modification Type), 2018-2029, $Million
Table 8.63: Spain Oligonucleotide Synthesis Market Revenue (by Application), 2018-2029, $Million
Table 8.64: Spain Oligonucleotide Synthesis Market Revenue (by Research Application), 2018-2029, $Million
Table 8.65: Spain Oligonucleotide Synthesis Market Revenue (by Therapeutic Application), 2018-2029, $Million
Table 8.66: Spain Oligonucleotide Synthesis Market Revenue (by End User), 2018-2029, $Million
Table 8.67: Rest-of-Europe Oligonucleotide Synthesis Market Revenue (by Product), 2018-2029, $Million
Table 8.68: Rest-of-Europe Synthesized Oligonucleotide Synthesis Market Revenue (by Synthesized Oligonucleotides), 2018-2029, $Milli
Table 8.69: Rest-of-Europe Synthesized Oligonucleotide Synthesis Market Revenue (by Modification Type), 2018-2029, $Million
Table 8.70: Rest-of-Europe Oligonucleotide Synthesis Market Revenue (by Application), 2018-2029, $Million
Table 8.71: Rest-of-Europe Oligonucleotide Synthesis Market Revenue (by Research Application), 2018-2029, $Million
Table 8.72: Rest-of-Europe Oligonucleotide Synthesis Market Revenue (by Therapeutic Application), 2018-2029, $Million
Table 8.73: Rest-of-Europe Oligonucleotide Synthesis Market Revenue (by End User), 2018-2029, $Million
Table 8.74: Asia-Pacific Oligonucleotide Synthesis Market Revenue (by Country), 2018-2029, $Million
Table 8.75: Asia-Pacific Oligonucleotide Synthesis Market Revenue (by Product), 2018-2029, $Million
Table 8.76: Asia-Pacific Synthesized Oligonucleotide Synthesis Market Revenue (by Synthesized Oligonucleotides), 2018-2029, $Million
Table 8.77: Asia-Pacific Synthesized Oligonucleotide Synthesis Market Revenue (by Modification Type), 2018-2029, $Million
Table 8.78: Asia-Pacific Oligonucleotide Synthesis Market Revenue (by Application), 2018-2029, $Million
Table 8.79: Asia-Pacific Oligonucleotide Synthesis Market Revenue (by Research Application), 2018-2029, $Million
Table 8.80: Asia-Pacific Oligonucleotide Synthesis Market Revenue (by Therapeutic Application), 2018-2029, $Million
Table 8.81: Asia-Pacific Oligonucleotide Synthesis Market Revenue (by End User), 2018-2029, $Million
Table 8.82: China Oligonucleotide Synthesis Market Revenue (by Product), 2018-2029, $Million
Table 8.83: China Synthesized Oligonucleotide Synthesis Market Revenue (by Synthesized Oligonucleotides), 2018-2029, $Million
Table 8.84: China Synthesized Oligonucleotide Synthesis Market Revenue (by Modification Type), 2018-2029, $Million
Table 8.85: China Oligonucleotide Synthesis Market Revenue (by Application), 2018-2029, $Million
Table 8.86: China Oligonucleotide Synthesis Market Revenue (by Research Application), 2018-2029, $Million
Table 8.87: China Oligonucleotide Synthesis Market Revenue (by Therapeutic Application), 2018-2029, $Million
Table 8.88: China Oligonucleotide Synthesis Market Revenue (by End User), 2018-2029, $Million
Table 8.89: Japan Oligonucleotide Synthesis Market Revenue (by Product), 2018-2029, $Million
Table 8.90: Japan Synthesized Oligonucleotide Synthesis Market Revenue (by Synthesized Oligonucleotides), 2018-2029, $Million
Table 8.91: Japan Synthesized Oligonucleotide Synthesis Market Revenue (by Modification Type), 2018-2029, $Million
Table 8.92: Japan Oligonucleotide Synthesis Market Revenue (by Application), 2018-2029, $Million
Table 8.93: Japan Oligonucleotide Synthesis Market Revenue (by Research Application), 2018-2029, $Million
Table 8.94: Japan Oligonucleotide Synthesis Market Revenue (by Therapeutic Application), 2018-2029, $Million
Table 8.95: Japan Oligonucleotide Synthesis Market Revenue (by End User), 2018-2029, $Million
Table 8.96: India Oligonucleotide Synthesis Market Revenue (by Product), 2018-2029, $Million
Table 8.97: India Synthesized Oligonucleotide Synthesis Market Revenue (by Synthesized Oligonucleotides), 2018-2029, $Million
Table 8.98: India Synthesized Oligonucleotide Synthesis Market Revenue (by Modification Type), 2018-2029, $Million
Table 8.99: India Oligonucleotide Synthesis Market Revenue (by Application), 2018-2029, $Million
Table 8.100: India Oligonucleotide Synthesis Market Revenue (by Research Application), 2018-2029, $Million
Table 8.101: India Oligonucleotide Synthesis Market Revenue (by Therapeutic Application), 2018-2029, $Million
Table 8.102: India Oligonucleotide Synthesis Market Revenue (by End User), 2018-2029, $Million
Table 8.103: Rest-of-APAC Oligonucleotide Synthesis Market Revenue (by Product), 2018-2029, $Million
Table 8.104: Rest-of-APAC Synthesized Oligonucleotide Synthesis Market Revenue (by Synthesized Oligonucleotides), 2018-2029, $Million
Table 8.105: Rest-of-APAC Synthesized Oligonucleotide Synthesis Market Revenue (by Modification Type), 2018-2029, $Million
Table 8.106: Rest-of-APAC Oligonucleotide Synthesis Market Revenue (by Application), 2018-2029, $Million
Table 8.107: Rest-of-APAC Oligonucleotide Synthesis Market Revenue (by Research Application), 2018-2029, $Million
Table 8.108: Rest-of-APAC Oligonucleotide Synthesis Market Revenue (by Therapeutic Application), 2018-2029, $Million
Table 8.109: Rest-of-APAC Oligonucleotide Synthesis Market Revenue (by End User), 2018-2029, $Million
Table 8.110: Latin America Oligonucleotide Synthesis Market Revenue (by Product), 2018-2029, $Million
Table 8.111: Latin America Synthesized Oligonucleotide Synthesis Market Revenue (by Synthesized Oligonucleotides), 2018-2029, $Million
Table 8.112: Latin America Synthesized Oligonucleotide Synthesis Market Revenue (by Modification Type), 2018-2029, $Million
Table 8.113: Latin America Oligonucleotide Synthesis Market Revenue (by Application), 2018-2029, $Million
Table 8.114: Latin America Oligonucleotide Synthesis Market Revenue (by Research Application), 2018-2029, $Million
Table 8.115: Latin America Oligonucleotide Synthesis Market Revenue (by Therapeutic Application), 2018-2029, $Million
Table 8.116: Latin America Oligonucleotide Synthesis Market Revenue (by End User), 2018-2029, $Million
Table 8.117: Middle East and Africa Oligonucleotide Synthesis Market Revenue (by Product), 2018-2029, $Million
Table 8.118: Middle East and Africa Synthesized Oligonucleotide Synthesis Market Revenue (by Synthesized Oligonucleotides), 2018-2029, $Million
Table 8.119: Middle East and Africa Synthesized Oligonucleotide Synthesis Market Revenue (by Modification Type), 2018-2029, $Million
Table 8.120: Middle East and Africa Oligonucleotide Synthesis Market Revenue (by Application), 2018-2029, $Million
Table 8.121: Middle East and Africa Oligonucleotide Synthesis Market Revenue (by Research Application), 2018-2029, $Million
Table 8.122: Middle East and Africa Oligonucleotide Synthesis Market Revenue (by Therapeutic Application), 2018-2029, $Million
Table 8.123: Middle East and Africa Oligonucleotide Synthesis Market Revenue (by End User), 2018-2029, $Million

List of Figures

Figure 1: Impact of Market Drivers and Market Restraints on the Global Oligonucleotide Synthesis Market
Figure 2: Global Oligonucleotide Synthesis Market Snapshot
Figure 3: Dominant Segments of the Global Oligonucleotide Synthesis Market, 2019 and 2029
Figure 4: Global Oligonucleotide Synthesis Market (by Product), 2019 and 2029
Figure 5: Global Oligonucleotide Synthesis Market (by Applications), 2019 and 2029
Figure 6: Global Oligonucleotide Synthesis Market (by End User), 2019 and 2029
Figure 7: Global Oligonucleotide Synthesis Market (by Region), 2019 and 2029
Figure 1.1: Global Oligonucleotide Synthesis Market, 2018-2029
Figure 2.1: Market Dynamics of Global Oligonucleotide Synthesis Market
Figure 3.1: Share of Key Developments and Strategies, (January 2016 – April 2019)
Figure 3.2: Product Launches Share (by Companies), January 2016 – April 2019
Figure 3.3: Acquisitions Share (by Companies), January 2016 – April 2019
Figure 3.4: Synergistic Activities Share (by Companies), January 2016 – April 2019
Figure 3.5: Synergistic Activities Share (by Companies), January 2016 – April 2019
Figure 3.6: Market Share Analysis for the Global Oligonucleotide Synthesis Market, 2017
Figure 3.7: Market Share Analysis for the Global Oligonucleotide Synthesis Market, 2018
Figure 3.8: Growth Share Matrix for Global Oligonucleotide Synthesis Market (by Companies), 2018
Figure 4.1: Oligonucleotide Drug Clinical Trials Pipeline Analysis, till June 2019 (Industry Sponsored: Active and Completed)
Figure 5.1: Oligonucleotide Synthesis Market, by Product, 2019 and 2029 ($Million)
Figure 5.2: Synthesized Oligonucleotides Market, by Product, 2019 and 2029 ($Million)
Figure 5.3: Synthesized Oligonucleotide Market, by Type, 2019 and 2029 ($Million)
Figure 6.1: Oligonucleotide Synthesis Market, by Application, 2019 and 2029 ($Million)
Figure 7.1: Oligonucleotide Synthesis Market, by End User, 2019 and 2029 ($Million)
Figure 8.1: Oligonucleotide Synthesis Market, by Region, 2019 and 2029 ($Million)
Figure 8.2: North America: Market Dynamics
Figure 8.3: Projections of the Older Adult Population in the U.S.: 2020 to 2060 (Million)
Figure 8.4: Europe: Market Dynamics
Figure 8.5: Pharmaceutical R&D Expenditure in Europe, $Million (2015-2017)
Figure 8.6: Germany Research Based Pharmaceutical R&D Expenditure, $Billion (2011-2016)
Figure 8.7: APAC: Market Dynamics
Figure 8.8: Latin America: Market Dynamics
Figure 9.1: Total Number of Companies Profiled
Figure 9.2:    Agilent Technologies: Overall Product Portfolio
Figure 9.3:    Agilent Technologies: Overall Financials, 2016-2018
Figure 9.4:    Agilent Technologies: Revenue (by Segment), 2016-2018
Figure 9.5:    Agilent Technologies: Revenue (by Region), 2016-2018
Figure 9.6:    Agilent Technologies: R&D Expenditure, 2016-2018
Figure 9.7:    Agilent Technologies: SWOT Analysis
Figure 9.8:    ATDBio Ltd.: Overall Product Portfolio
Figure 9.9:    ATDBio Ltd.: SWOT Analysis
Figure 9.10:    Bio-Synthesis Inc.: Overall Product Portfolio
Figure 9.11:    Bio-Synthesis Inc.: SWOT Analysis
Figure 9.12:    Eurofins Scientific SE: Product Portfolio
Figure 9.13:    Eurofins Scientific SE: Overall Financials, 2016-2018
Figure 9.14:    Eurofins Scientific SE: Revenue (by region), 2016-2018
Figure 9.15:    Eurofins Scientific SE: SWOT Analysis
Figure 9.16:    Kaneka Eurogentec S.A.: Overall Product Portfolio
Figure 9.17:    Kaneka Eurogentec S.A.: SWOT Analysis
Figure 9.18:    GE Healthcare: Overall Product Portfolio
Figure 9.19:    General Electric Company: Overall Financials, 2016-2018
Figure 9.20:    General Electric Company: Revenue (by Segment), 2016-2018
Figure 9.21:    General Electric Company: Revenue Split for Healthcare, 2016-2018
Figure 9.22:    General Electric: Healthcare Revenue (by Region), 2016-2018
Figure 9.23:    General Electric Company: R&D Expenditure, 2016-2018
Figure 9.24:    General Electric Company: SWOT Analysis
Figure 9.25:    TriLink BioTechnologies, LLC.: Overall Product Portfolio
Figure 9.26:    TriLink BioTechnologies, LLC: SWOT Analysis
Figure 9.27:    GenScript Biotech Corp: Overall Product Portfolio
Figure 9.28:    GenScript Biotech Corp: Overall Financials, 2016-2018
Figure 9.29:    GenScript Biotech Corp: Revenue (by Segment), 2016-2018
Figure 9.30:    GenScript Biotech Corp: Revenue (by Region), 2016-2018
Figure 9.31:    GenScript Biotech Corp: R&D Expenditure, 2016-2018
Figure 9.32:    GenScript Biotech Corp: SWOT Analysis
Figure 9.33:    Ajinomoto Co., Inc.: Overall Product Portfolio
Figure 9.34:    Ajinomoto Co., Inc.: Overall Financials, 2016-2018
Figure 9.35:    Ajinomoto Co., Inc.: Revenue (by Segment), 2016-2018
Figure 9.36:    Ajinomoto Co., Inc.: Revenue (by Region), 2016-2018
Figure 9.37:    Ajinomoto Co., Inc.: R&D Expenditure, 2016-2018
Figure 9.38:    Ajinomoto Co., Inc.: SWOT Analysis
Figure 9.39:    Biolegio B.V.: Overall Product Portfolio
Figure 9.40:    Biolegio B.V.: SWOT Analysis
Figure 9.41:    Danaher Corporation: Overall Product Portfolio
Figure 9.42:    Danaher Corporation: Overall Financials, 2016-2018
Figure 9.43:    Danaher Corporation: Revenue (by Business Segment), 2016-2018
Figure 9.44:    Danaher Corporation: Revenue (by Region), 2016-2018
Figure 9.45:    Danaher Corporation: R&D Expenditure, 2016-2018
Figure 9.46:    Danaher Corporation: SWOT Analysis
Figure 9.47:    Microsynth AG: Overall Product Portfolio
Figure 9.48:    Microsynth AG: SWOT Analysis
Figure 9.49:    Merck KGaA: Overall Product Portfolio
Figure 9.50:    Merck KGaA: Overall Financials, 2016-2018
Figure 9.51:    Merck KGaA: Revenue (by Segment), 2016-2018
Figure 9.52:    Merck KGaA: Revenue (by Region), 2016-2018
Figure 9.53:    Merck KGaA: R&D Expenditure, 2016-2018
Figure 9.54:    Merck KGaA: SWOT Analysis
Figure 9.55:    LGC Limited: Overall Product Portfolio
Figure 9.56:    LGC Limited: Overall Financials, 2017-2018
Figure 9.57:    LGC Limited: Revenue (by Segment), 2017-2018
Figure 9.58:    LGC Limited: Revenue (by Region), 2018
Figure 9.59:    LGC Limited: R&D Expenditure, 2017-2018
Figure 9.60:    LGC Limited: SWOT Analysis
Figure 9.61:    Thermo Fisher Scientific Inc.: Overall Product Portfolio
Figure 9.62:    Thermo Fisher Scientific Inc.: Overall Financials, 2016-2018
Figure 9.63:    Thermo Fisher Scientific Inc.: Revenue (by Segment), 2016-2018
Figure 9.64:    Thermo Fisher Scientific Inc.: Revenue (by Region), 2016-2018
Figure 9.65:    Thermo Fisher Scientific Inc.: R&D Expenditure, 2016-2018
Figure 9.66:    Thermo Fisher Scientific Inc.: SWOT Analysis
Figure 10.1:    Global Oligonucleotide Synthesis Market Segmentation
Figure 10.2:    Global Oligonucleotide Synthesis Market Research Methodology
Figure 10.3:    Primary Research
Figure 10.4:    Secondary Research
Figure 10.5:    Data Triangulation
Figure 10.6:    Bottom-Up Approach (Segment-Wise Analysis)
Figure 10.7:    Top-Down Approach (Segment-Wise Analysis)
Figure 10.8:    Assumptions and Limitations
Figure 10.9:    Considered Factors for Data Prediction and Modelling